These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8447550)

  • 41. Use of prothrombin complex concentrates in the treatment of a hemophilic patient with an inhibitor of factor VIII.
    Sonoda T; Solomon A; Krauss S; Cruz P; Jones FS; Levin J
    Blood; 1976 Jun; 47(6):983-9. PubMed ID: 1276480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Case report: successful use of antifibrinolytic therapy in acquired factor VIII deficiency.
    Lalwani RB; Stricker RB
    Am J Med Sci; 1992 Jun; 303(6):398-401. PubMed ID: 1605170
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful peritoneal dialysis in a hemophilia A patient with factor VIII inhibitor.
    Solak Y; Turkmen K; Atalay H; Turk S
    Perit Dial Int; 2010; 30(1):114-6. PubMed ID: 20056993
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors.
    Unuvar A; Kavakli K; Baytan B; Kazanci E; Sayli T; Oren H; Celkan T; Gursel T
    Haemophilia; 2008 Mar; 14(2):315-22. PubMed ID: 18081830
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
    Klukowska A; Zieleniewska B
    Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibitors of factor VIII: detection and treatment.
    Brettler DB
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():21-5. PubMed ID: 7886576
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epsilon-aminocaproic acid inhibits the activity of factor VIII inhibitors in patients with severe haemophilia A in vivo and in vitro.
    Ghosh K; Shetty S; Pathare A; Mohanty D
    Acta Haematol; 2000; 103(2):67-72. PubMed ID: 10838448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Severe postoperative hemorrhage caused by antibody-mediated coagulation factor deficiencies: report of two cases.
    Miura T; Ban D; Koyama T; Kudo A; Ochiai T; Irie T; Nakamura N; Tanaka S; Arii S
    Surg Today; 2014 May; 44(5):976-81. PubMed ID: 23695294
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Continuous infusion of porcine factor VIII in the management of patients with factor VIII inhibitors.
    Rubinger M; Houston DS; Schwetz N; Woloschuk DM; Israels SJ; Johnston JB
    Am J Hematol; 1997 Oct; 56(2):112-8. PubMed ID: 9326353
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Successful treatment of acquired hemophilia A with recombinant porcine factor VIII].
    Trautmann-Grill K; Tiebel O; Hölig K; Platzbecker U
    Med Klin Intensivmed Notfmed; 2019 Nov; 114(8):746-748. PubMed ID: 29774375
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current concepts in the management of hemophilia.
    Abildgaard CF
    Semin Hematol; 1975 Jul; 12(3):223-32. PubMed ID: 1079631
    [No Abstract]   [Full Text] [Related]  

  • 52. The management of factor VIII inhibitors in non-hemophilic patients.
    Green D
    Prog Clin Biol Res; 1984; 150():337-52. PubMed ID: 6431438
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies.
    Holme PA; Brosstad F; Tjønnfjord GE
    Haemophilia; 2005 Sep; 11(5):510-5. PubMed ID: 16128896
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transient factor VIII inhibitor in a hemophilia patient after staphylococcal septic shock syndrome.
    Yamamoto K; Niiya K; Shigematu T; Kiguchi T; Takenaka K; Shinagawa K; Ishimaru F; Ikeda K; Shima M; Harada M
    Int J Hematol; 2000 Dec; 72(4):517-9. PubMed ID: 11197224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of immune tolerance in patients with hemophilia A and inhibitors.
    Gruppo RA; Valdez LP; Stout RD
    Am J Pediatr Hematol Oncol; 1992; 14(1):82-7. PubMed ID: 1550269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surgery for a chronic cystic hematoma on the right thigh in a hemophiliac A with a potent factor VIII inhibitor.
    Masuhara K; Shimizu T; Kawasaki N; Fukui H; Sakai Y; Shima M; Mikami S; Yoshioka A
    Nihon Seikeigeka Gakkai Zasshi; 1982 Dec; 56(12):1719-27. PubMed ID: 6820658
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of inhibitor patients with activated prothrombin complex concentrates.
    Penner JA
    Prog Clin Biol Res; 1984; 150():291-308. PubMed ID: 6431434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Successful treatment of acquired hemophilia with oral immunosuppressive therapy.
    Shaffer LG; Phillips MD
    Ann Intern Med; 1997 Aug; 127(3):206-9. PubMed ID: 9245226
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of bleeds in hemophilia patients with inhibitors: emerging data and clinical direction.
    Leissinger CA
    Am J Hematol; 2004 Oct; 77(2):187-93. PubMed ID: 15389908
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Preliminary experience with achieving immune tolerance in patients with hemophilia A and circulating factor VIII inhibitor].
    Scharf R; Kucharski W; Lopaciuk S; Celińska W; Dmytrow A; Domański K; Gonet S; Miastkowski Z; Nowakowska I; Przybylski A
    Acta Haematol Pol; 1991; 22(1):92-9. PubMed ID: 1823972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.